243 related articles for article (PubMed ID: 31719675)
21. Outcomes of Eyes Lost to Follow-up with Proliferative Diabetic Retinopathy That Received Panretinal Photocoagulation versus Intravitreal Anti-Vascular Endothelial Growth Factor.
Obeid A; Su D; Patel SN; Uhr JH; Borkar D; Gao X; Fineman MS; Regillo CD; Maguire JI; Garg SJ; Hsu J
Ophthalmology; 2019 Mar; 126(3):407-413. PubMed ID: 30077614
[TBL] [Abstract][Full Text] [Related]
22. Single-Dose Intravitreal Conbercept before Panretinal Photocoagulation as an Effective Adjunctive Treatment in Chinese Proliferative Diabetic Retinopathy.
Zhang Q; Zhang T; Zhuang H; Sun Z; Qin Y
Ophthalmologica; 2019; 242(2):59-68. PubMed ID: 30699427
[TBL] [Abstract][Full Text] [Related]
23. Factors Associated with Worsening Proliferative Diabetic Retinopathy in Eyes Treated with Panretinal Photocoagulation or Ranibizumab.
Bressler SB; Beaulieu WT; Glassman AR; Gross JG; Jampol LM; Melia M; Peters MA; Rauser ME;
Ophthalmology; 2017 Apr; 124(4):431-439. PubMed ID: 28161147
[TBL] [Abstract][Full Text] [Related]
24. Long-term real-world outcomes of retinal microvasculature changes in proliferative diabetic retinopathy treated with panretinal photocoagulation vs. intravitreal conbercept.
Li Z; Zhou L; Huang C; Lu T; Liang J; Cong Q; Lan Y; Jin C
Microvasc Res; 2023 Nov; 150():104586. PubMed ID: 37451332
[TBL] [Abstract][Full Text] [Related]
25. Characteristics of Retinal Neovascularization in Proliferative Diabetic Retinopathy Imaged by Optical Coherence Tomography Angiography.
Ishibazawa A; Nagaoka T; Yokota H; Takahashi A; Omae T; Song YS; Takahashi T; Yoshida A
Invest Ophthalmol Vis Sci; 2016 Nov; 57(14):6247-6255. PubMed ID: 27849310
[TBL] [Abstract][Full Text] [Related]
26. Retinal Nonperfusion Characteristics on Ultra-Widefield Angiography in Eyes With Severe Nonproliferative Diabetic Retinopathy and Proliferative Diabetic Retinopathy.
Nicholson L; Ramu J; Chan EW; Bainbridge JW; Hykin PG; Talks SJ; Sivaprasad S
JAMA Ophthalmol; 2019 Jun; 137(6):626-631. PubMed ID: 30973596
[TBL] [Abstract][Full Text] [Related]
27. Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema.
Mirshahi A; Shenazandi H; Lashay A; Faghihi H; Alimahmoudi A; Dianat S
Retina; 2010 Feb; 30(2):254-9. PubMed ID: 20057344
[TBL] [Abstract][Full Text] [Related]
28. Effects of an intravitreal bevacizumab injection combined with panretinal photocoagulation on high-risk proliferative diabetic retinopathy.
Shin YW; Lee YJ; Lee BR; Cho HY
Korean J Ophthalmol; 2009 Dec; 23(4):266-72. PubMed ID: 20046686
[TBL] [Abstract][Full Text] [Related]
29. Comparison between panretinal photocoagulation and panretinal photocoagulation plus intravitreal bevacizumab in proliferative diabetic retinopathy.
Ahmad M; Jan S
J Ayub Med Coll Abbottabad; 2012; 24(3-4):10-3. PubMed ID: 24669597
[TBL] [Abstract][Full Text] [Related]
30. Retinal Nonperfusion in Proliferative Diabetic Retinopathy Before and After Panretinal Photocoagulation Assessed by Widefield OCT Angiography.
Russell JF; Al-Khersan H; Shi Y; Scott NL; Hinkle JW; Fan KC; Lyu C; Feuer WJ; Gregori G; Rosenfeld PJ
Am J Ophthalmol; 2020 May; 213():177-185. PubMed ID: 32006481
[TBL] [Abstract][Full Text] [Related]
31. Retinal vein changes in patients with high-risk proliferative diabetic retinopathy treated with conbercept and panretinal photocoagulation co-therapy: a cohort study.
Si M; Tao Y; Zhang Z; Zhao H; Cui W; Yang M; Wang H
Front Endocrinol (Lausanne); 2023; 14():1218442. PubMed ID: 37693359
[TBL] [Abstract][Full Text] [Related]
32. Repeated intravitreal bevacizumab (Avastin(®)) treatment of persistent new vessels in proliferative diabetic retinopathy after complete panretinal photocoagulation.
Schmidinger G; Maar N; Bolz M; Scholda C; Schmidt-Erfurth U
Acta Ophthalmol; 2011 Feb; 89(1):76-81. PubMed ID: 21272288
[TBL] [Abstract][Full Text] [Related]
33. Intravitreal Aflibercept injection with Panretinal photocoagulation versus early Vitrectomy for diabetic vitreous hemorrhage: randomized clinical trial.
Abd Elhamid AH; Mohamed AAEA; Khattab AM
BMC Ophthalmol; 2020 Apr; 20(1):130. PubMed ID: 32252674
[TBL] [Abstract][Full Text] [Related]
34. Panretinal photocoagulation versus intravitreal injection retreatment pain in high-risk proliferative diabetic retinopathy.
Lucena CR; Ramos Filho JA; Messias AM; Silva JA; Almeida FP; Scott IU; Ribeiro JA; Jorge R
Arq Bras Oftalmol; 2013; 76(1):18-20. PubMed ID: 23812521
[TBL] [Abstract][Full Text] [Related]
35. A randomized controlled trial of panretinal photocoagulation with and without intravitreal ranibizumab in treatment-naive eyes with non-high-risk proliferative diabetic retinopathy.
Ferraz DA; Vasquez LM; Preti RC; Motta A; Sophie R; Bittencourt MG; Sepah YJ; Monteiro ML; Nguyen QD; Takahashi WY
Retina; 2015 Feb; 35(2):280-7. PubMed ID: 25272318
[TBL] [Abstract][Full Text] [Related]
36. Panretinal photocoagulation plus intravitreal conbercept for diabetic retinopathy in real world: a retrospective study.
Wang X; Yao J; Li S; Zhang W; Wang L; Zhou A
BMC Ophthalmol; 2023 Oct; 23(1):400. PubMed ID: 37794367
[TBL] [Abstract][Full Text] [Related]
37. Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.
Gross JG; Glassman AR; Liu D; Sun JK; Antoszyk AN; Baker CW; Bressler NM; Elman MJ; Ferris FL; Gardner TW; Jampol LM; Martin DF; Melia M; Stockdale CR; Beck RW;
JAMA Ophthalmol; 2018 Oct; 136(10):1138-1148. PubMed ID: 30043039
[TBL] [Abstract][Full Text] [Related]
38. Intravitreal bevacizumab and/or macular photocoagulation as a primary treatment for diffuse diabetic macular edema.
Solaiman KA; Diab MM; Abo-Elenin M
Retina; 2010; 30(10):1638-45. PubMed ID: 20838357
[TBL] [Abstract][Full Text] [Related]
39. Effects of intravitreal injection of ranibizumab on choroidal structure and blood flow in eyes with diabetic macular edema.
Okamoto M; Yamashita M; Ogata N
Graefes Arch Clin Exp Ophthalmol; 2018 May; 256(5):885-892. PubMed ID: 29492689
[TBL] [Abstract][Full Text] [Related]
40. Prediction of regression of retinal neovascularisation after panretinal photocoagulation for proliferative diabetic retinopathy.
Chatziralli IP; Sergentanis TN; Sivaprasad S
Graefes Arch Clin Exp Ophthalmol; 2016 Sep; 254(9):1715-21. PubMed ID: 26802035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
